Atopic Dermatitis – ACT17207

A Phase 2, randomized, double-blind, placebo controlled, multicenter proof-of-concept study evaluating efficacy and safety of rilzabrutinib in adult patients with moderate-to-severe atopic dermatitis who are inadequate responders or intolerant to topical corticosteroids. Register Today!

Read More

Plaque Psoriasis (CAIN2322)

Plaque Psoriasis (CAIN2322)

Psoriasis is an autoimmune disease that causes raised, red, scaly patches to appear on the skin. It typically affects the outside of the elbows, knees or scalp, though it can appear on any location. Some people report that psoriasis is itchy, burns and stings. Psoriasis can be associated with rheumatoid arthritis, Crohn’s disease, and osteoporosis….

Read More

Crohn’s Disease (M14-433/431)

Crohn’s Disease (M14-433/431)

Crohn’s disease is an inflammatory bowel disease (IBD). It causes inflammation of the lining of your digestive tract, which can lead to abdominal pain, severe diarrhea, fatigue, weight loss and malnutrition. Inflammation caused by Crohn’s disease can involve different areas of the digestive tract in different people. The inflammation caused by Crohn’s disease often spreads…

Read More

Endometriosis-Associated Pain (M14-702)

Endometriosis-Associated Pain (M14-702)

Endometriosis is an often times painful disorder in which tissue that normally lines the inside of your uterus, the endometrium, grows outside your uterus. The objective of this study is to evaluate safety and efficacy of elagolix in the management of moderate to severe endometriosis-associated pain in adult premenopausal female subjects including the safety and efficacy…

Read More